With the development of nanotechnology and confronting the problems of traditional
pharmaceutical formulations in treating lung diseases, inhalable nano-formulations have …

Drug delivery by inhalation is the principal strategy to treat obstructive lung diseases, which
affect about 15% of the population in the United States. Aerosol delivery devices have …

Lipid nanoparticles (LNPs) have demonstrated efficacy and safety for mRNA vaccine
administration by intramuscular injection; however, the pulmonary delivery of mRNA …

Objectives In this review paper, we explore the interaction between the functioning
mechanism of different nebulizers and the physicochemical properties of the formulations for …

Protein inhalation is a delivery route which offers high potential for direct local lung
application of proteins. Liquid formulations are usually available in early stages of …

Background Inhaled colistin is becoming increasingly popular against respiratory tract
infections caused by multidrug resistant (MDR) Gram-negative bacteria because it may …

Incremental gains in understanding the influence of various factors on aerosol delivery in
concert with technological advancements over the past 2 decades have fueled an ever …

The delivery of aerosols to mechanically ventilated patients presents unique challenges and
differs from inhaled drug delivery in spontaneously breathing patients in several respects …

Nebulizers have a number of advantages for the delivery of inhaled pharmaceutical
aerosols, including the use of aqueous formulations and the ability to deliver process …

Presently, non-invasive targeted drug delivery to the lungs represents a routinely
investigated approach to treat challenging disorders such as pulmonary fibrosis. Nintedanib …